76 related articles for article (PubMed ID: 17250806)
21. Agonists and Antagonists of TGF-β Family Ligands.
Chang C
Cold Spring Harb Perspect Biol; 2016 Aug; 8(8):. PubMed ID: 27413100
[TBL] [Abstract][Full Text] [Related]
22. Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities.
Krupska I; Bruford EA; Chaqour B
Hum Genomics; 2015 Sep; 9():24. PubMed ID: 26395334
[TBL] [Abstract][Full Text] [Related]
23. Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system.
Malik AR; Liszewska E; Jaworski J
Front Cell Neurosci; 2015; 9():237. PubMed ID: 26157362
[TBL] [Abstract][Full Text] [Related]
24. The role of CCN family genes in haematological malignancies.
Wells JE; Howlett M; Cheung LC; Kees UR
J Cell Commun Signal; 2015 Sep; 9(3):267-78. PubMed ID: 26026820
[TBL] [Abstract][Full Text] [Related]
25. WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling.
Maeda A; Ono M; Holmbeck K; Li L; Kilts TM; Kram V; Noonan ML; Yoshioka Y; McNerny EM; Tantillo MA; Kohn DH; Lyons KM; Robey PG; Young MF
J Biol Chem; 2015 May; 290(22):14004-18. PubMed ID: 25864198
[TBL] [Abstract][Full Text] [Related]
26. Targeted mutation of NOV/CCN3 in mice disrupts joint homeostasis and causes osteoarthritis-like disease.
Roddy KA; Boulter CA
Osteoarthritis Cartilage; 2015 Apr; 23(4):607-15. PubMed ID: 25541297
[TBL] [Abstract][Full Text] [Related]
27. The CCN family proteins: modulators of bone development and novel targets in bone-associated tumors.
Chen PC; Cheng HC; Yang SF; Lin CW; Tang CH
Biomed Res Int; 2014; 2014():437096. PubMed ID: 24551846
[TBL] [Abstract][Full Text] [Related]
28. The role of the CCN family of proteins in female reproduction.
Winterhager E; Gellhaus A
Cell Mol Life Sci; 2014 Jun; 71(12):2299-311. PubMed ID: 24448904
[TBL] [Abstract][Full Text] [Related]
29. The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia.
Suresh S; McCallum L; Crawford LJ; Lu WH; Sharpe DJ; Irvine AE
J Pathol; 2013 Nov; 231(3):378-87. PubMed ID: 24308033
[TBL] [Abstract][Full Text] [Related]
30. Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.
Cisternas P; Henriquez JP; Brandan E; Inestrosa NC
Mol Neurobiol; 2014 Feb; 49(1):574-89. PubMed ID: 24014138
[TBL] [Abstract][Full Text] [Related]
31. Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic β-cell function.
Paradis R; Lazar N; Antinozzi P; Perbal B; Buteau J
PLoS One; 2013; 8(5):e64957. PubMed ID: 23705021
[TBL] [Abstract][Full Text] [Related]
32. CCN3 protein participates in bone regeneration as an inhibitory factor.
Matsushita Y; Sakamoto K; Tamamura Y; Shibata Y; Minamizato T; Kihara T; Ito M; Katsube K; Hiraoka S; Koseki H; Harada K; Yamaguchi A
J Biol Chem; 2013 Jul; 288(27):19973-85. PubMed ID: 23653360
[TBL] [Abstract][Full Text] [Related]
33. The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature.
Chatakun P; Núñez-Toldrà R; Díaz López EJ; Gil-Recio C; Martínez-Sarrà E; Hernández-Alfaro F; Ferrés-Padró E; Giner-Tarrida L; Atari M
Cell Mol Life Sci; 2014 Jan; 71(1):113-42. PubMed ID: 23568025
[TBL] [Abstract][Full Text] [Related]
34. CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis.
Ouellet V; Siegel PM
J Cell Commun Signal; 2012 Jun; 6(2):73-85. PubMed ID: 22427255
[TBL] [Abstract][Full Text] [Related]
35. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.
Jun JI; Lau LF
Nat Rev Drug Discov; 2011 Dec; 10(12):945-63. PubMed ID: 22129992
[TBL] [Abstract][Full Text] [Related]
36. Distinct bone morphogenetic proteins activate indistinguishable transcriptional responses in nephron epithelia including Notch target genes.
Larman BW; Karolak MJ; Lindner V; Oxburgh L
Cell Signal; 2012 Jan; 24(1):257-64. PubMed ID: 21945409
[TBL] [Abstract][Full Text] [Related]
37. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation.
Lin GL; Hankenson KD
J Cell Biochem; 2011 Dec; 112(12):3491-501. PubMed ID: 21793042
[TBL] [Abstract][Full Text] [Related]
38. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
39. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
Guillon-Munos A; Oikonomopoulou K; Michel N; Smith CR; Petit-Courty A; Canepa S; Reverdiau P; Heuzé-Vourc'h N; Diamandis EP; Courty Y
J Biol Chem; 2011 Jul; 286(29):25505-18. PubMed ID: 21628462
[TBL] [Abstract][Full Text] [Related]
40. First structural glimpse of CCN3 and CCN5 multifunctional signaling regulators elucidated by small angle x-ray scattering.
Holbourn KP; Malfois M; Acharya KR
J Biol Chem; 2011 Jun; 286(25):22243-9. PubMed ID: 21543320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
